BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38238853)

  • 1. LINC00571 drives tricarboxylic acid cycle metabolism in triple-negative breast cancer through HNRNPK/ILF2/IDH2 axis.
    Xi Z; Huang H; Hu J; Yu Y; Ma X; Xu M; Ming J; Li L; Zhang H; Chen H; Huang T
    J Exp Clin Cancer Res; 2024 Jan; 43(1):22. PubMed ID: 38238853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRNDE-h transcript/miR-136-5p axis regulates interleukin enhancer binding factor 2 expression to promote hepatocellular carcinoma cell proliferation.
    Shiu TY; Lin HH; Shih YL; Feng AC; Huang HH; Huang TY; Hsieh CB; Chang WK; Hsieh TY
    Life Sci; 2021 Nov; 284():119708. PubMed ID: 34153299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FGD5-AS1 facilitates glioblastoma progression by activation of Wnt/β-catenin signaling via regulating miR-129-5p/HNRNPK axis.
    Wu L; Zhu X; Song Z; Guo M; Liang J; Yan D
    Life Sci; 2020 Sep; 256():117998. PubMed ID: 32585241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin enhancer-binding factor 2 promotes cell proliferation and DNA damage response in metastatic melanoma.
    Zhang X; Bustos MA; Gross R; Ramos RI; Takeshima TL; Mills GB; Yu Q; Hoon DSB
    Clin Transl Med; 2021 Oct; 11(10):e608. PubMed ID: 34709752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA MIDEAS-AS1 inhibits growth and metastasis of triple-negative breast cancer via transcriptionally activating NCALD.
    Luo D; Liang Y; Wang Y; Ye F; Jin Y; Li Y; Han D; Wang Z; Chen B; Zhao W; Wang L; Chen X; Jiang L; Yang Q
    Breast Cancer Res; 2023 Sep; 25(1):109. PubMed ID: 37770991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneous nuclear ribonucleoprotein K promotes the progression of lung cancer by inhibiting the p53-dependent signaling pathway.
    Li M; Yang X; Zhang G; Wang L; Zhu Z; Zhang W; Huang H; Gao R
    Thorac Cancer; 2022 May; 13(9):1311-1321. PubMed ID: 35352475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA SNHG8 enhances triple-negative breast cancer cell proliferation and migration by regulating the miR-335-5p/PYGO2 axis.
    Qian J; Lei X; Sun Y; Zheng L; Li J; Zhang S; Zhang L; Li W; Shi J; Jia W; Tang T
    Biol Direct; 2021 Aug; 16(1):13. PubMed ID: 34362407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine-Induced ILF2 Facilitates Nuclear mRNA Export of Pluripotency Factors to Promote Stemness and Chemoresistance in Human Esophageal Cancer.
    Li Y; Wang M; Yang M; Xiao Y; Jian Y; Shi D; Chen X; Ouyang Y; Kong L; Huang X; Bai J; Hu Y; Lin C; Song L
    Cancer Res; 2021 Jul; 81(13):3525-3538. PubMed ID: 33975879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and Critical Role of Interleukin Enhancer Binding Factor 2 in Hepatocellular Carcinoma.
    Cheng S; Jiang X; Ding C; Du C; Owusu-Ansah KG; Weng X; Hu W; Peng C; Lv Z; Tong R; Xiao H; Xie H; Zhou L; Wu J; Zheng S
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27556459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA ST8SIA6-AS1 promotes cell proliferation and metastasis in triple-negative breast cancer by targeting miR-145-5p/CDCA3 to inactivate the p53/p21 signaling pathway.
    Qiao Y; Wang B; Yan Y; Niu L
    Environ Toxicol; 2022 Oct; 37(10):2398-2411. PubMed ID: 35730485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA FTO-IT1 promotes glycolysis and progression of hepatocellular carcinoma through modulating FTO-mediated N6-methyladenosine modification on GLUT1 and PKM2.
    Wang F; Hu Y; Wang H; Hu P; Xiong H; Zeng Z; Han S; Wang D; Wang J; Zhao Y; Huang Y; Zhuo W; Lv G; Zhao G
    J Exp Clin Cancer Res; 2023 Oct; 42(1):267. PubMed ID: 37840133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA T376626 is a promising serum biomarker and promotes proliferation, migration, and invasion via binding to LAMC2 in triple-negative breast cancer.
    He Y; Xiao B; Lei T; Xuan J; Zhu Y; Kuang Z; Liu J; He J; Li L; Sun Z
    Gene; 2023 Apr; 860():147227. PubMed ID: 36709879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long Noncoding RNA pancEts-1 Promotes Neuroblastoma Progression through hnRNPK-Mediated β-Catenin Stabilization.
    Li D; Wang X; Mei H; Fang E; Ye L; Song H; Yang F; Li H; Huang K; Zheng L; Tong Q
    Cancer Res; 2018 Mar; 78(5):1169-1183. PubMed ID: 29311158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA NEAT1 confers oncogenic role in triple-negative breast cancer through modulating chemoresistance and cancer stemness.
    Shin VY; Chen J; Cheuk IW; Siu MT; Ho CW; Wang X; Jin H; Kwong A
    Cell Death Dis; 2019 Mar; 10(4):270. PubMed ID: 30894512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulated expression of ILF2 in non-small cell lung cancer is associated with tumor cell proliferation and poor prognosis.
    Ni T; Mao G; Xue Q; Liu Y; Chen B; Cui X; Lv L; Jia L; Wang Y; Ji L
    J Mol Histol; 2015 Oct; 46(4-5):325-35. PubMed ID: 26059795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneous Nuclear Ribonucleoprotein K Is Involved in the Estrogen-Signaling Pathway in Breast Cancer.
    Iwabuchi E; Miki Y; Suzuki T; Hirakawa H; Ishida T; Sasano H
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33806648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA WEE2-AS1 promotes proliferation and inhibits apoptosis in triple negative breast cancer cells via regulating miR-32-5p/TOB1 axis.
    Wang R; Huang Z; Qian C; Wang M; Zheng Y; Jiang R; Yu C
    Biochem Biophys Res Commun; 2020 Jun; 526(4):1005-1012. PubMed ID: 32307083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circ-GALNT16 restrains colorectal cancer progression by enhancing the SUMOylation of hnRNPK.
    Peng C; Tan Y; Yang P; Jin K; Zhang C; Peng W; Wang L; Zhou J; Chen R; Wang T; Jin C; Ji J; Feng Y; Tang J; Sun Y
    J Exp Clin Cancer Res; 2021 Aug; 40(1):272. PubMed ID: 34452628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosomal delivery of 7SK long non-coding RNA suppresses viability, proliferation, aggressiveness and tumorigenicity in triple negative breast cancer cells.
    Farhadi S; Mohammadi-Yeganeh S; Kiani J; Hashemi SM; Koochaki A; Sharifi K; Ghanbarian H
    Life Sci; 2023 Jun; 322():121646. PubMed ID: 37011870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The circRNA circIFI30 promotes progression of triple-negative breast cancer and correlates with prognosis.
    Xing L; Yang R; Wang X; Zheng X; Yang X; Zhang L; Jiang R; Ren G; Chen J
    Aging (Albany NY); 2020 Jun; 12(11):10983-11003. PubMed ID: 32497020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.